Profil
Arvinder Dhalla is currently Vice President-Clinical Operations at Rani Therapeutics LLC and Vice President-Clinical Development at Rani Therapeutics Holdings, Inc. Formerly, Dr. Dhalla was Biology Director-Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Education includes a doctorate from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Aktive Positionen von Arvinder Dhalla
| Unternehmen | Position | Beginn |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Geschäftsführer | - |
Ehemalige bekannte Positionen von Arvinder Dhalla
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Arvinder Dhalla
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panjab University Chandigarh
Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
















